Titan America SA Common Shares (TTAM)
16.75
-0.47 (-2.73%)
NYSE · Last Trade: Jan 20th, 3:25 PM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
